Black Bird Biotech Announces S

FLOWER MOUND, TX/ACCESSWIRE/June 7, 2022/ Black Bird Biotech, Inc. (OTC PINK:BBBT), maker of herbal MiteXstreamMT biopesticide, today announced that, in additional independent laboratory testing, MiteXstreamMT has been shown to be “NON-TOXIC” to honey bees when they ingest the biopesticide. The Honey Bee oral toxicity report can be viewed here.

The company previously announced that MiteXstreamMT tested as “NON-TOXIC” to honey bees when contacted topically (report can be found here).

“MiteXstreamMT is now laboratory proven to be completely non-toxic to bees. This, coupled with its high efficiency and cost-effectiveness, will provide us with leverage as we seek to expand sales channels,” said Fabian Deneault, President of BBBT. “These results demonstrate the revolutionary capabilities of MiteXstreamMT brings to the many facets of the agricultural industry.”

High-performance laboratory:

STILLMEADOW, Inc., Sugar Land, Texas.

Director of studies:

Cole Younger, PhD., Entomologist, STILLMEADOW, Inc.

The study:

MiteXstream: Honey bee, Apis melliferaAcute oral toxicity limit test.

The conclusion:

With 0% mortality after 48 hoursMiteXstream was non-toxic if swallowed by honey bees.

According to Fortune Business Insights™, the biopesticides market is expected to be worth $10.63 billion by 2027 growing at a CAGR of 13.1%, the growth of which will be driven by increasing research activities to develop new microbial products.

A USDA report stated, “As the world’s most important group of pollinators, bees are a crucial component of agricultural production and natural ecosystem function.”

Black Bird Biotech is proud to offer the MiteXstreamMT product that is both an effective means of controlling pests including mites, molds and other harmful agricultural problems, while being tested as non-toxic to honey bees.

MiteXstreamMT is currently available on and the MiteXstream Amazon® store.

For news and updates, shareholders, potential investors and potential business partners are encouraged to follow @BBBT_Corporate on Twitter and @BlackBirdBiotech on Instagram. Also visit BBBT’s corporate website,, for more information about the company.

About BBBT

Black Bird Biotech is positioned to tap into market segments with powerful and reinvented biotech products. Its EPA-registered biopesticide, MiteXstreamMTeradicates mites and similar pests, including spider mites (a deadly pest of cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamMT is a pesticide, but it’s not a poison – it’s a reinvented pesticide. The MiteXstreamMT Advantage: Use throughout the harvest day without worrying about residual “pesticide” violations, including state cannabis testing. MiteXstreamMT is the cornerstone of the business that holds vast potential worldwide as a highly effective, safe and extremely cost-effective substitute for many traditional “toxic” pesticides.

Forward-looking statements:

This press release contains “forward-looking statements,” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. contained in this press release that are forward-looking statements are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including, but not limited to, products sold or cash flow from operations.

Actual results could differ from those projected in the forward-looking statements due to many factors. These factors include, among others, the inherent uncertainties associated with distribution and the difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this press release, and we undertake no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be correct. Investors should review all of the information presented here and should also refer to our most recent annual report for our most recently completed fiscal year, our quarterly reports and other periodic reports filed from time to time with the Securities and Exchange Commission.

Eric Newlan
vice president
[email protected]

THE SOURCE: Black Bird Biotech, Inc.

See the source version on


Comments are closed.